Drug shortage
Semaglutide Injection · Novo Nordisk, Inc.
FDA drug shortage · Resolved · updated Feb 21, 2025
Key facts
| Generic name | Semaglutide Injection |
|---|---|
| Proprietary name | Wegovy |
| Company | Novo Nordisk, Inc. |
| Presentation | Wegovy, Injection, .5 mg/.5 mL (NDC 0169-4505-14) |
| Dosage form | Injection |
| Strength | .5 mg/.5 mL |
| Status | Resolved |
| Therapeutic category | Endocrinology/Metabolism |
| Package NDCs | 0169-4505-14 |
| First posted | Mar 31, 2022 |
| Last updated | Feb 21, 2025 |
At a glance
- 1–9 Package NDCs affected
- 1–9 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: